Revium Rx (RVRC) Retained Earnings (2024 - 2025)

Revium Rx (RVRC) reported Retained Earnings of $31.8 million for Q4 2025, up 4.59% on a YoY basis from $30.4 million in Q4 2024, and up 4.59% sequentially from $30.4 million in Q4 2024.

Revium Rx (RVRC) Retained Earnings (2024 - 2025) Analysis & Trends

Revium Rx (RVRC) has 2 years of Retained Earnings data on file, last reported at $31.8 million in Q4 2025.

  • For the quarter ending Q4 2025, Retained Earnings rose 4.59% year-over-year to $31.8 million; the trailing twelve-month figure through Dec 2025 stood at $31.8 million (up 4.59% YoY), and the FY2025 full-year result was $31.8 million, up 4.59% from the prior year.
  • Retained Earnings rose to $31.8 million in Q4 2025, from $30.4 million in the prior quarter.
  • In the past five years, Retained Earnings ranged from a high of $31.8 million in Q4 2025 to a low of $30.4 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Retained Earnings (Qtr)
1 Veeva Systems 29.34 Bn 22.03 Bn 662.02 Mn -19.79 Mn
2 BrightSpring Health Services 13.49 Bn 12.59 Bn 482.22 Mn 14.14 Mn
3 Healthequity 7.96 Bn 7.70 Bn 256.31 Mn 1.90 Bn
4 10x Genomics 6.17 Bn 5.63 Bn 106.18 Mn 114,000.00
5 Hinge Health 6.02 Bn 5.70 Bn 154.23 Mn -348,000.00
6 MiniMed 4.19 Bn 3.89 Bn 480.00 Mn -12.00 Mn
7 Waystar Holding 4.14 Bn 4.07 Bn 216.84 Mn 846,000.00
8 Doximity 3.82 Bn 3.08 Bn 125.97 Mn 28,000.00
9 Privia Health 3.10 Bn 2.73 Bn - 905.05 Mn
10 Revium Rx 101.42 Mn 98.71 Mn - 31.78 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 31.78 Mn
Dec 31, 2024 30.39 Mn